Cargando…

Urolithin B suppressed osteoclast activation and reduced bone loss of osteoporosis via inhibiting ERK/NF‐κB pathway

OBJECTIVES: The main target of current drugs for alleviating bone loss is osteoclasts. However, the long‐term application of such drugs will also cause side effects. Therefore, it is of great need to develop new and safer therapeutics for osteoporosis. In recent years, drug development based on gut...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Yajun, Zhuang, Qi, Tao, Lihong, Zheng, Kai, Chen, Shuangshuang, Yang, Yunshang, Feng, Chengcheng, Wang, Zhifang, Shi, Haiwei, Shi, Jiandong, Fang, Yiling, Xiao, Long, Geng, Dechun, Wang, Zhirong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2022
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9528769/ https://www.ncbi.nlm.nih.gov/pubmed/35708050 http://dx.doi.org/10.1111/cpr.13291

Ejemplares similares

BushenHuoxue decoction suppresses M1 macrophage polarization and prevents LPS induced inflammatory bone loss by activating AMPK pathway
por: Chen, Shuangshuang, et al.
Publicado: (2023)

Paeoniflorin Ameliorates Hyperprolactinemia-Induced Inhibition of Osteoblastogenesis by Suppressing the NF-κB Signaling Pathway
por: Sun, Xiaohong, et al.
Publicado: (2022)

Activation of dopamine receptor D1 promotes osteogenic differentiation and reduces glucocorticoid-induced bone loss by upregulating the ERK1/2 signaling pathway
por: Zhu, Jie, et al.
Publicado: (2022)

The Dopamine D1 Receptor Attenuates Titanium Particle-Induced Inhibition of Osteogenesis by Activating the Wnt Signaling Pathway
por: Feng, Chengcheng, et al.
Publicado: (2023)

Reciprocal Role of ERK and Nf-κb Pathways in Survival and Activation of Osteoclasts
por: Miyazaki, Tsuyoshi, et al.
Publicado: (2000)

Puerarin alleviates osteoporosis in the ovariectomy-induced mice by suppressing osteoclastogenesis via inhibition of TRAF6/ROS-dependent MAPK/NF-κB signaling pathways
por: Xiao, Long, et al.
Publicado: (2020)

Strontium inhibits titanium particle-induced osteoclast activation and chronic inflammation via suppression of NF-κB pathway
por: Zhu, Shijun, et al.
Publicado: (2016)

Nur77 Prevents Osteoporosis by Inhibiting the NF‐κB Signalling Pathway and Osteoclast Differentiation
por: Tian, Huanlian, et al.
Publicado: (2022)

Aconine attenuates osteoclast-mediated bone resorption and ferroptosis to improve osteoporosis via inhibiting NF-κB signaling
por: Xue, Chunchun, et al.
Publicado: (2023)

Gut Metabolite Urolithin A Inhibits Osteoclastogenesis and Senile Osteoporosis by Enhancing the Autophagy Capacity of Bone Marrow Macrophages
por: Tao, Huaqiang, et al.
Publicado: (2022)

The gut microbiota metabolite urolithin A inhibits NF-κB activation in LPS stimulated BMDMs
por: Abdelazeem, Khalid N. M., et al.
Publicado: (2021)

Effects of urolithin A on osteoclast differentiation induced by receptor activator of nuclear factor-κB ligand via bone morphogenic protein 2
por: Wang, Zhe, et al.
Publicado: (2022)

Vindoline Attenuates Osteoarthritis Progression Through Suppressing the NF-κB and ERK Pathways in Both Chondrocytes and Subchondral Osteoclasts
por: Zhu, Meisong, et al.
Publicado: (2022)

Amyloid β Peptide Enhances RANKL-Induced Osteoclast Activation through NF-κB, ERK, and Calcium Oscillation Signaling
por: Li, Shangfu, et al.
Publicado: (2016)

Urolithin B, a newly identified regulator of skeletal muscle mass
por: Rodriguez, Julie, et al.
Publicado: (2017)

Urolithin B: Two-way attack on IAPP proteotoxicity with implications for diabetes
por: Raimundo, Ana F., et al.
Publicado: (2022)

DUSP6 expression is associated with osteoporosis through the regulation of osteoclast differentiation via ERK2/Smad2 signaling
por: Zhang, Boya, et al.
Publicado: (2021)

Lithium chloride inhibits titanium particle-induced osteoclastogenesis by inhibiting the NF-κB pathway
por: Hu, Xuanyang, et al.
Publicado: (2017)

Anti-Osteoclast Effect of Exportin-1 Inhibitor Eltanexor on Osteoporosis Depends on Nuclear Accumulation of IκBα–NF-κB p65 Complex
por: Chen, Junchun, et al.
Publicado: (2022)

Metformin attenuates osteoclast-mediated abnormal subchondral bone remodeling and alleviates osteoarthritis via AMPK/NF-κB/ERK signaling pathway
por: Guo, Haohui, et al.
Publicado: (2021)

Up‐regulated CST5 inhibits bone resorption and activation of osteoclasts in rat models of osteoporosis via suppression of the NF‐κB pathway
por: Wang, Fei, et al.
Publicado: (2019)

Protective Effects of Punicalagin on Osteoporosis by Inhibiting Osteoclastogenesis and Inflammation via the NF-κB and MAPK Pathways
por: Wang, Wei, et al.
Publicado: (2020)

Urolithin A alleviates neuropathic pain and activates mitophagy
por: Wang, Chenyi, et al.
Publicado: (2023)

Microbial Metabolite Urolithin B Inhibits Recombinant Human Monoamine Oxidase A Enzyme
por: Singh, Rajbir, et al.
Publicado: (2020)

Foxf1 gene increases the risk of osteoporosis in rats by inhibiting osteoblast formation and promoting osteoclast differentiation through the upregulation of NF-κB pathway
por: Ouyang, Xiao, et al.
Publicado: (2022)

Dehydrocostus lactone attenuates osteoclastogenesis and osteoclast‐induced bone loss by modulating NF‐κB signalling pathway
por: Hu, Bin, et al.
Publicado: (2019)

Sustained Release of Melatonin from GelMA Liposomes Reduced Osteoblast Apoptosis and Improved Implant Osseointegration in Osteoporosis
por: Xiao, Long, et al.
Publicado: (2020)

The role of MicroRNAs in Osteoclasts and Osteoporosis
por: Tang, Peifu, et al.
Publicado: (2015)

Membrane trafficking in osteoclasts and implications for osteoporosis
por: Ng, Pei Ying, et al.
Publicado: (2019)

Urolithin and Reduced Urolithin Derivatives as Potent Inhibitors of Tyrosinase and Melanogenesis: Importance of the 4-Substituted Resorcinol Moiety
por: Lee, Sanggwon, et al.
Publicado: (2021)

Cyperenoic acid suppresses osteoclast differentiation and delays bone loss in a senile osteoporosis mouse model by inhibiting non-canonical NF-κB pathway
por: Chawalitpong, Supatta, et al.
Publicado: (2018)

Bajijiasu Abrogates Osteoclast Differentiation via the Suppression of RANKL Signaling Pathways through NF-κB and NFAT
por: Hong, Guoju, et al.
Publicado: (2017)

The Gut Microbiota Metabolite Urolithin B Prevents Colorectal Carcinogenesis by Remodeling Microbiota and PD-L1/HLA-B
por: Wang, Lixue, et al.
Publicado: (2023)

Zoledronic acid inhibits osteoclast differentiation and function through the regulation of NF-κB and JNK signalling pathways
por: Huang, Xiao-Lin, et al.
Publicado: (2019)

Urolithin A and B Alter Cellular Metabolism and Induce Metabolites Associated with Apoptosis in Leukemic Cells
por: Alzahrani, Abdulaziz Musa, et al.
Publicado: (2021)

Inhibition of Osteoblast Functions by IKK/NF-κB in Osteoporosis
por: Chang, Jia, et al.
Publicado: (2009)

Interleukin-17A upregulates receptor activator of NF-κB on osteoclast precursors
por: Adamopoulos, Iannis E, et al.
Publicado: (2010)

Inhibition of Osteoclast Differentiation by Carotenoid Derivatives through Inhibition of the NF-κB Pathway
por: Odes-Barth, Shlomit, et al.
Publicado: (2020)

Vericiguat Modulates Osteoclast Differentiation and Bone Resorption via a Balance between VASP and NF-κB Pathways
por: Sun, Kaiqiang, et al.
Publicado: (2022)

Blockade of NF-κB and MAPK pathways by ulinastatin attenuates wear particle-stimulated osteoclast differentiation in vitro and in vivo
por: Ru, Jiang-Ying, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_rgcj4ussi96er6e0771fs8dajf